Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Prothena reported $700.34M in Current Assets for its fiscal quarter ending in March of 2023.

Current Assets Change
Acadia Pharmaceuticals ACAD:US USD 502.85M 5.09M
Agios Pharmaceuticals AGIO:US USD 791.66M 41.12M
Akebia Therapeutics AKBA:US USD 120.72M 64.23M
Alnylam Pharmaceuticals ALNY:US USD 2.54B 151.23M
Amgen AMGN:US USD 44.7B 22.52B
Biogen BIIB:US USD 9.76B 28.7M
BioMarin Pharmaceutical BMRN:US USD 2.84B 90.65M
Bluebird Bio BLUE:US USD 351.07M 151.58M
Exelixis EXEL:US USD 1.64B 18.86M
Immunic Inc. VTL:US USD 106.58M 19.28M
Incyte Corp INCY:US USD 3.97B 121.22M
Intercept Pharmaceuticals ICPT:US USD 490.46M 49.67M
Intra Cellular Therapies ITCI:US USD 706.09M 31.86M
Ionis Pharmaceuticals IONS:US USD 2.54B 339.92M
MacroGenics MGNX:US USD 288.94M 66.76M
Nektar Therapeutics NKTR:US USD 491.07M 54.9M
Neurocrine Biosciences NBIX:US USD 1.43B 20.7M
Prothena PRTA:US USD 700.34M 18.76M
Regeneron Pharmaceuticals REGN:US USD 16.91B 1.03B
Seattle Genetics SGEN:US USD 2.6B 200.62M
Ultragenyx Pharmaceutical RARE:US USD 766.34M 117.56M
Vertex Pharmaceuticals VRTX:US USD 12.97B 269.1M